Stay updated on PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T11:24:35.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the access-denied page.
    Difference
    0.3%
    Check dated 2026-10-18T11:42:51.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the study record page still displays a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-10-11T13:27:41.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, blocking access to the trial record details (MK-3475-042/KEYNOTE-042) and related content.
    Difference
    20%
    Check dated 2026-09-20T14:12:54.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page now includes a funding attribution for 2014 (U.S. NIH Grant/Contract) and shows an updated Revision: v3.6.6. The Plain Language Summary and the older Revision: v3.6.5 have been removed, resulting in a streamlined public-facing page.
    Difference
    0.2%
    Check dated 2026-08-29T23:35:33.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page. There are no specific content changes described in the provided data.
    Difference
    0.1%
    Check dated 2026-08-08T17:07:01.000Z thumbnail image

Stay in the know with updates to PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ Lung Cancer: Pembrolizumab vs Chemotherapy Clinical Trial page.